Vavricka John sold AVIR
January 31, 2026 · Form 4 insider transaction
Vavricka John sold 8,750 shares of Atea Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,750
Price
$0.00
Total value
N/A
InsiderVavricka John
RoleOfficer
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateJanuary 31, 2026
Filing dateFebruary 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.; Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026.